Company / Total Assets
Denali Therapeutics Inc. Total Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.1B
FY2025
5-year range
$1.1B / $1.5B
FY2021-FY2025
Trend
-16.7%
vs FY2024
Sector context
#72 of 214
Health Care
What the data says
At $1.1B, Denali Therapeutics Inc.'s total assets ranks #72 of 214 in the Health Care sector. Total Assets has fluctuated over the past 9 years, ranging from $487M in FY2017 to $1.6B in FY2020.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of -6.5%.
Remained stable around $1.1B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -7.8%
- 5-Year CAGR
- -6.5%
- 10-Year CAGR
- -
Sector benchmark
#72 of 214 in Health CareTop 34% of 214This company $1.1B Sector average $7.5B
▼
-84.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -6.5%, indicating a declining trend.
- In FY2025, total assets decreased 16.7% year-over-year.
- Ranks #72 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.73 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | -16.7% |
| FY2024 | $1.4B | +19.1% |
| FY2023 | $1.2B | -21.0% |
| FY2022 | $1.5B | +4.0% |
| FY2021 | $1.4B | -12.5% |
| FY2020 | $1.6B | +190.0% |
| FY2019 | $553.2M | -16.4% |
| FY2018 | $662.0M | +36.0% |
| FY2017 | $486.7M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026